Tanimoto Sarina

CHIEF MEDICAL OFFICER, 10% OwnerARS Pharmaceuticals, Inc. (SPRY) · full profile →Form 4 · filed Aug 21, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$704K
Net Open-Market Flow
-$704K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 20, 2025Sell(S)38K$14.09$531K1.2M
Aug 19, 2025Sell(S)12K$14.03$173K1.3M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-25-022638) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about SPRY insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001415889-25-022638"
Ask your agent
Use Arkolith to summarize insider buying and selling at ARS Pharmaceuticals, Inc.
over the last 90 days and cite the filings.